A detailed history of Journey Strategic Wealth LLC transactions in Novartis Ag stock. As of the latest transaction made, Journey Strategic Wealth LLC holds 2,775 shares of NVS stock, worth $268,564. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,775
Previous 2,748 0.98%
Holding current value
$268,564
Previous $292,000 9.25%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$106.13 - $120.89 $2,865 - $3,264
27 Added 0.98%
2,775 $319,000
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $23,327 - $27,057
252 Added 10.1%
2,748 $292,000
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $237,793 - $270,741
2,496 New
2,496 $241,000
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $178,222 - $218,254
2,359 New
2,359 $214,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $208B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Journey Strategic Wealth LLC Portfolio

Follow Journey Strategic Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Strategic Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Strategic Wealth LLC with notifications on news.